Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial.
Hu Y, Zhang ZY, Wang F, Zhuang K, Xu X, Liu DS, Fan HZ, Yang L, Jiang K, Zhang DK, Xu L, Tang JH, Liu XM, He C, Shu X, Xie Y, Lau JYW, Zhu Y, Du YQ, Graham DY, Lu NH. Hu Y, et al. Among authors: shu x. Lancet Microbe. 2024 Dec 18:100975. doi: 10.1016/j.lanmic.2024.100975. Online ahead of print. Lancet Microbe. 2024. PMID: 39708826 Free article.
Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection.
Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori; Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD, Zhou LY, Chen Y, Zeng ZR, Wang CW, Xiao SD, Pan GZ, Hu PJ. Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori, et al. J Dig Dis. 2013 May;14(5):211-21. doi: 10.1111/1751-2980.12034. J Dig Dis. 2013. PMID: 23302262 No abstract available.
Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.
Xie Y, Zhu Y, Zhou H, Lu ZF, Yang Z, Shu X, Guo XB, Fan HZ, Tang JH, Zeng XP, Wen JB, Li XQ, He XX, Ma JH, Liu DS, Huang CB, Xu NJ, Wang NR, Lu NH. Xie Y, et al. Among authors: shu x. World J Gastroenterol. 2014 Aug 28;20(32):11415-21. doi: 10.3748/wjg.v20.i32.11415. World J Gastroenterol. 2014. PMID: 25170230 Free PMC article. Clinical Trial.
Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.
Hong J, Shu X, Liu D, Zhu Y, Xie C, Xie Y, Zhang K, Wang A, Xiong H, Zeng H, Yu H, Ma J, Chen Y, Zhu X, Lu N. Hong J, et al. Among authors: shu x. J Antimicrob Chemother. 2016 Aug;71(8):2280-5. doi: 10.1093/jac/dkw118. Epub 2016 Apr 21. J Antimicrob Chemother. 2016. PMID: 27107097 Clinical Trial.
3,756 results